<HTML>
<HEAD>
<TITLE>AOD Thesaurus Annotated Hierarchy: chemical substances by structure ZM ZN22</TITLE>
<META
Name="Description"sA Guide to Concepts and Terminology in Substance Abuse and Addiction">
</META>
<META
Name="Keywords"
Content="classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept">
</META>
</HEAD>
<body bgcolor="#FFFFFF">
<CENTER><B><BIG>AOD Thesaurus.&nbsp;&nbsp;Annotated Hierarchy.&nbsp;&nbsp;chemical substances by structure.&nbsp;&nbsp;ZM - ZN22</BIG></B></Center>
<CENTER><A HREF="aodob.htm#Z">b-out</A>&nbsp;&nbsp;To Broad Outline&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#ZM">d-out</A>&nbsp;&nbsp;To Detailed Outline&nbsp;&nbsp;&nbsp;&nbsp;
<A HREF="aodhqz.htm">qh</A>&nbsp;&nbsp;To Quick Hierarchy</CENTER>
<CENTER><A HREF="aodhnzj.htm">Previous</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm">Next</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodwsrch.htm">Search</A></CENTER><BR><BR>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZM"><B><BIG>ZM</BIG></B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B><BIG>organic nitrogen compounds</BIG></B>&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#ZM"><SMALL>d-out</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZM"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">NT</TD><TD>+YCe enzymes &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YC"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YC"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZJ4.8.2e nitriles &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ4-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ4-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZN amines, imines, and imides &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZO amino acids, peptides, and proteins &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZPe alkaloids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ZDe organic compounds &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZD"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZD"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZM2"><B>ZM2</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>nitrophenol</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZM2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ZF4e phenols &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZF4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZF4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZM4"><B>ZM4</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>verapamil</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZM4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">BT</TD><TD>+YL6e antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YL6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YL6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT8.14e calcium channel blockers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZM6"><B>ZM6</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>urea</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZM6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">RT</TD><TD><TT>&nbsp;</TT>EB16.2 urea cycle &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EB16-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EB16-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>HF2e urinalysis &nbsp;&nbsp;&nbsp;<A HREF="aodhqha.htm#HF2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnha.htm#HF2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>XB2.10.4e urine &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XB2-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#XB2-10-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZM8"><B>ZM8</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>phenformin</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZM8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">RT</TD><TD><TT>&nbsp;</TT>GR4.14e hypoglycemia &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GR4-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngo.htm#GR4-14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN"><B>ZN</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>amines, imines, and imides</B>&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#ZN"><SMALL>d-out</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">BT</TD><TD>+ZMe organic nitrogen compounds &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZM"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZM"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2">ZN2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>amines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD>+YH2.2 amine hormones &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YH2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YH2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YX4.2.2e nitrosamine &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX4-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YX4-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZK2.4.2.2.4.2e phosphatidylethanolamine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZK2-4-2-2-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZK2-4-2-2-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.10.12.4e serotonin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-10-12-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZU6.2e mecamylamine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZU6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzu.htm#ZU6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YC14.6 amine oxidoreductases &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YC14-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YC14-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZO amino acids, peptides, and proteins &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-4">ZN2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>propylamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZT8.14.10e promethazine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-14-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT8-14-10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-4-2">ZN2.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>fluoxetine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP4.8.2.2e serotonergic anti-alcohol-craving agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.12.6 agents for alcohol-concurrent depression &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV6.6.2e serotonin uptake inhibitors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-4-4">ZN2.4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>citalopram&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP4.8.2.2e serotonergic anti-alcohol-craving agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV6.6.2e serotonin uptake inhibitors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-8">ZN2.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>catecholamines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+ZN2.18.2.2e biogenic monoamines &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-18-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-8-2">ZN2.8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>dobutamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-8-4">ZN2.8.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>dopa&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">ST</TD><TD> 3,4-dihydroxyphenylalanine </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YV4.2 dopaminergic agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZO2e amino acids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZO2.2.2.12e phenylalanine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO2-2-2-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO2-2-2-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YH2.2.6e epinephrine &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YH2-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YH2-2-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YH2.2.6.6e norepinephrine &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YH2-2-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YH2-2-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.10.10e melanin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-10-10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-8-4-2">ZN2.8.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>L-dopa&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-8-4-4">ZN2.8.4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>cysteinyldopa&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-8-4-6">ZN2.8.4.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>levodopa&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8-4-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-8-4-8">ZN2.8.4.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>methyldopa&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8-4-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-8-4-8-2">ZN2.8.4.8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>carbidopa&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8-4-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-8-6">ZN2.8.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>dopamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>YH2.2.6.2 deoxyepinephrine &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YH2-2-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YH2-2-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YJ2e neurotransmitters &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YJ2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YJ2.4e monoamine neurotransmitters &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YJ2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV4.2 dopaminergic agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZN2.18.2.2e biogenic monoamines &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-18-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>FP12.4e euphoria &nbsp;&nbsp;&nbsp;<A HREF="aodhqf.htm#FP12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnfl.htm#FP12-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>XU4.8.4e adrenal medulla &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XU4-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxr.htm#XU4-8-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YK6.6e dopaminergic receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YL6e antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YL6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YL6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZP24.2e tetrahydroisoquinoline &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP24-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP24-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZP24.2.2e salsolinol &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP24-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP24-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-8-6-2">ZN2.8.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>hydroxydopamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-10">ZN2.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>ethylamines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-10-2">ZN2.10.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>fenfluramine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-10-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.8.8 schedule IV appetite suppressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT2e appetite suppressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV14e sympathomimetics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-10-2-2">ZN2.10.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>norfenfluramine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-10-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-10-4">ZN2.10.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>phenylethylamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-10-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>BF2.2 mescaline &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BF2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BF2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BJ2.2e amphetamines &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BJ2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BJ2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZN2.16.2.14e ritodrine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-16-2-14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-10-6">ZN2.10.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>phenoxybenzamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-10-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YT8.8 antihypertensive agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV6.6e serotonin antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV12.2e alpha-adrenergic receptor blockaders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV12-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-12">ZN2.12</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>fluvoxamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP4.2e anti-alcohol-intoxication agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.2.2e serotonergic anti-alcohol-craving agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.12.10 agents for alcohol-related cognitive impairment &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV6.6.2e serotonin uptake inhibitors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-14">ZN2.14</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>hydroxylamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-14-2">ZN2.14.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>oxime&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-14-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YD10.2 cholinesterase reactivators &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YD10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YD10-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-14-2-2">ZN2.14.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pralidoxime compound&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-14-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+YD10.2 cholinesterase reactivators &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YD10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YD10-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16">ZN2.16</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>amino alcohols&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">ST</TD><TD> alkylamine </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ZF2e alcohols (chemical class) &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZF2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZF2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2">ZN2.16.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>ethanolamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-2">ZN2.16.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>albuterol&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-4">ZN2.16.2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>phenylephrine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+YT8.4e vasoconstrictor agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT8.10 cardiotonic agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV2 bronchodilator agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV14.2.2e alpha-adrenergic receptor agonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV14-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV14-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-6">ZN2.16.2.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>sotalol&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+YV12.4e beta-adrenergic receptor blockaders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV12-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-8">ZN2.16.2.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>terbutaline&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-10">ZN2.16.2.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>choline&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-10-2">ZN2.16.2.10.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>succinylcholine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-10-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP4.8.10e conditioned alcohol aversion agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT6.6 neuromuscular depolarizing agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZJ2.12.2.4e succinate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-12-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-12-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-10-2-2">ZN2.16.2.10.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>succinylcholine chloride&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-10-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="37%"> </TD><TD WIDTH="5%">ST</TD><TD> Anectine </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+HK2.12.2e chemical aversion therapy &nbsp;&nbsp;&nbsp;<A HREF="aodhqhj.htm#HK2-12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnhj.htm#HK2-12-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-12">ZN2.16.2.12</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>isoproterenol&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-12-2">ZN2.16.2.12.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>heptaminol&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-12-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-12-4">ZN2.16.2.12.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>propanolamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-12-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-12-4-2">ZN2.16.2.12.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>propranolol&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-12-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="37%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.6.6 beta blockers for alcohol withdrawal &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.12.8 agents for alcohol-concurrent anxiety &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT8.2 antiarrhythmia agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT8.6e vasodilator agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT8.8 antihypertensive agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV12.4e beta-adrenergic receptor blockaders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV12-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-12-4-4">ZN2.16.2.12.4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>ephedrine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-12-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="37%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="37%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>From the plant Ephedra equisetina.  Chemically closely related to metamphetamine.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YW8e CNS stimulants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-14">ZN2.16.2.14</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>ritodrine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+YV14.2.4e beta-adrenergic receptor agonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV14-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV14-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZN2.10.4e phenylethylamine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-10-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-16">ZN2.16.2.16</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>suloctidil&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-16"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+YT8.6e vasodilator agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-18">ZN2.16.2.18</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>atenolol&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-18"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP4.6.6 beta blockers for alcohol withdrawal &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-20">ZN2.16.2.20</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>methoxamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-20"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+YT8.4e vasoconstrictor agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-22">ZN2.16.2.22</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>metoprolol&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-22"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-24">ZN2.16.2.24</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nadolol&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-24"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-16-2-26">ZN2.16.2.26</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>timolol&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-26"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-18">ZN2.18</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>biogenic amines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YJ2e neurotransmitters &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YJ2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>ZG2.10e biogenic aldehyde &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZG2-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZG2-10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-18-2">ZN2.18.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>acetylcholine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YJ2e neurotransmitters &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YJ2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV4 neuroregulators &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>YC4.6.4.2.2e acetylcholinesterase &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YC4-6-4-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YC4-6-4-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-18-2-2">ZN2.18.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>biogenic monoamines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">NT</TD><TD>+YH2.2.6.6e norepinephrine &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YH2-2-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YH2-2-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZN2.8e catecholamines &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZN2.8.6e dopamine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT6.10.12e tryptamine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-10-12"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-18-2-2-2">ZN2.18.2.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>histamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD><TD WIDTH="5%">BT</TD><TD>+YJ2e neurotransmitters &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YJ2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YM14 slow-reacting substances &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YM14"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+BX2.2.4e congener &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BX2-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BX2-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YKe receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-18-2-2-2-2">ZN2.18.2.2.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>methylhistamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2-2-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="37%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-18-2-2-2-2-2">ZN2.18.2.2.2.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>R alpha methylhistamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2-2-2-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="39%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> MHA </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YQ2e anti-inflammatory agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YQ2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YQ2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-18-2-2-4">ZN2.18.2.2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>tyramine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD><TD WIDTH="5%">BT</TD><TD>+YV14e sympathomimetics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-18-2-2-4-2">ZN2.18.2.2.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>norsynephrine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2-2-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-18-2-2-4-4">ZN2.18.2.2.4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>synephrine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2-2-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-18-2-4">ZN2.18.2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>biogenic polyamines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-18-2-4-2">ZN2.18.2.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>cadaverine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-18-2-4-4">ZN2.18.2.4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>putrescine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-18-2-4-4-2">ZN2.18.2.4.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>spermidine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2-4-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-18-2-4-4-2-2">ZN2.18.2.4.4.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>spermine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2-4-4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20">ZN2.20</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>amine derivatives&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">NT</TD><TD>+ZO2e amino acids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-2">ZN2.20.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>amides&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+ZJ4.8e nitrogen-containing carboxylic acid derivative &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ4-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ4-8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-2-2">ZN2.20.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>acetamide&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">RT</TD><TD>+ZJ2.6.4e acetic acid &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-6-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-2-2-2">ZN2.20.2.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>piracetam&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-2-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ZT4.32.6e pyrrolidinone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-32-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-32-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-2-2-4">ZN2.20.2.2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>thioacetamide&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-2-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD><TD WIDTH="5%">BT</TD><TD>+YX4e carcinogens &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YX4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZN2.20.8.8e thioamide &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-8-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-20-8-8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-2-2-6">ZN2.20.2.2.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>phenacetin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-2-2-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD><TD WIDTH="5%">BT</TD><TD>+YR2.2.6 gout suppressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YR2-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YR2-2-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-4">ZN2.20.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>anilide&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-4-2">ZN2.20.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>acetanilide&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-4-4">ZN2.20.4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>acetaminophen&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">ST</TD><TD> paracetamol </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> Tylenol </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-4-4-2">ZN2.20.4.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>lidocaine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-4-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-6">ZN2.20.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>benzamides&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+ZJ2.10.10.2e benzoic acid &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-10-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-10-10-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-6-2">ZN2.20.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>hippurates&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+ZJ2.10.6e keto acids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-10-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-10-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-6-2-2">ZN2.20.6.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>aminohippuric acid&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-6-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-6-2-2-2">ZN2.20.6.2.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>p-aminohippuric acid&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-6-2-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-6-4">ZN2.20.6.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>tiapride&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP4.8.12.2 dopaminergic blockers for alcohol-concurrent mental disorders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-6-6">ZN2.20.6.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>metoclopramide&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-6-8">ZN2.20.6.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>procarbazine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-6-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+YQ6 antineoplastic agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YQ6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YQ6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YX4e carcinogens &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YX4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-6-10">ZN2.20.6.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>sulpiride&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-6-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+YW6e antidepressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-8">ZN2.20.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>sulfonamide&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YQ4e anti-infective agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YQ4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YQ4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-8-2">ZN2.20.8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>probenecid&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-8-4">ZN2.20.8.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>salicylazosulfapyridine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-8-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-8-6">ZN2.20.8.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>sulfanilamide&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-8-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-8-6-2">ZN2.20.8.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>furosemide&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-8-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-8-6-4">ZN2.20.8.6.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>sulfadiazine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-8-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-8-6-4-2">ZN2.20.8.6.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>silver sulfadiazine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-8-6-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-8-6-6">ZN2.20.8.6.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>sulfamethoxazole&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-8-6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-8-6-8">ZN2.20.8.6.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>sulfapyridine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-8-6-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-8-6-10">ZN2.20.8.6.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>sulfisoxazole&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-8-6-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-8-8">ZN2.20.8.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>thioamide&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-8-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZN2.20.2.2.4e thioacetamide &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-2-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-20-2-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-10">ZN2.20.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>aniline compounds&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-20-14">ZN2.20.14</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>phenylenediamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN2-22">ZN2.22</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>carbinolamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-22"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN4">ZN4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>imines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN4-2">ZN4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>polyethyleneimine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN6">ZN6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>imides&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZN6-2">ZN6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>succinimide&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YW4.6e anticonvulsants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZJ2.12.2.4e succinate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-12-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-12-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT4.32.6e pyrrolidinone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-32-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-32-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
</TABLE><BR><BR>
<CENTER><A HREF="aodob.htm#Z">b-out</A>&nbsp;&nbsp;To Broad Outline&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#ZM">d-out</A>&nbsp;&nbsp;To Detailed Outline&nbsp;&nbsp;&nbsp;&nbsp;
<A HREF="aodhqz.htm">qh</A>&nbsp;&nbsp;To Quick Hierarchy</CENTER>
<CENTER><A HREF="aodhnzj.htm">Previous</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm">Next</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodwsrch.htm">Search</A></CENTER><P>classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept </P>
</BODY>
</HTML>
